<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Multiple Sclerosis on VitaminDWiki</title><link>/categories/multiple-sclerosis.html</link><description>Recent content in Multiple Sclerosis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 29 Oct 2011 00:00:00 +0000</lastBuildDate><atom:link href="/categories/multiple-sclerosis/index.xml" rel="self" type="application/rss+xml"/><item><title>MS worse with Vitamin D2</title><link>/posts/ms-worse-with-vitamin-d2.html</link><pubDate>Sat, 29 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/ms-worse-with-vitamin-d2.html</guid><description>&lt;h2 id="multiple-sclerosis-and-vitamin-dhttpwwwneurologyorgcontent7717e99short">&lt;a href="http://www.neurology.org/content/77/17/e99.short">Multiple sclerosis and vitamin D&lt;/a>&lt;/h2>
&lt;h2 id="random-controlled-trial-with-6000-iu-of-vitamin-d2">Random controlled trial with 6,000 IU of vitamin D2&lt;/h2>
&lt;p>While the high-dose group did reach higher levels of vitamin D, there were no significant differences between the groups in regard to MRI changes.&lt;/p>
&lt;p>The high-dose group actually had significantly more relapses and worse disability than the low-dose group at the end of the study&lt;/p>
&lt;p>PDF is attached to the bottom of this page&lt;/p>
&lt;hr>
&lt;h1 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h1>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/chance-of-a-fall-decreased-with-vitamin-d3-but-increased-with-d2">Chance of a fall decreased with vitamin D3 but increased with D2 – Oct 2011&lt;/a>&lt;/p></description></item><item><title>Why has the MS latitude gradient disappeared</title><link>/posts/why-has-the-ms-latitude-gradient-disappeared.html</link><pubDate>Sat, 15 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/why-has-the-ms-latitude-gradient-disappeared.html</guid><description>&lt;h4 id="why-does-the-northsouth-gradient-of-incidence-of-multiple-sclerosis-seem-to-have-disappeared-on-the-northern-hemisphere">Why does the north–south gradient of incidence of multiple sclerosis seem to have disappeared on the Northern hemisphere?&lt;/h4>
&lt;p>Journal of the Neurological Sciences, doi:10.1016/j.jns.2011.09.003&lt;/p>
&lt;p>Nils Koch-Henriksen a, b, Per Soelberg Sorensen c, &lt;a href="mailto:pss@rh.dk">pss@rh.dk&lt;/a>&lt;/p>
&lt;p>a	Department of Neurology, Aarhus University Hospital in Aalborg, Denmark&lt;/p>
&lt;p>b	The Danish Multiple Sclerosis Registry, Neuroscience Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark&lt;/p>
&lt;p>c	Danish Multiple Sclerosis Center, University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark&lt;/p></description></item><item><title>CureTogether Vitamin D symptoms, treatments, and causes</title><link>/posts/curetogether-vitamin-d-symptoms-treatments-and-causes.html</link><pubDate>Fri, 14 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/curetogether-vitamin-d-symptoms-treatments-and-causes.html</guid><description>&lt;h1 id="curetogetherhttpcuretogethercomvitamin-d-deficiencysymptoms-is-an-excellent-source-on-100s-of-diseases">&lt;a href="http://curetogether.com/vitamin-d-deficiency/symptoms/">CureTogether&lt;/a> is an excellent source on 100&amp;rsquo;s of diseases&lt;/h1>
&lt;h3 id="a-hrefpostsspan-stylecolorf00click-herespan-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-4933span-stylecolorf00click-herespana-for-update-dec-2013">&lt;a href="/posts/span-stylecolorf00click-herespan" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 4933">&lt;span style="color:#F00;">CLICK HERE&lt;/span>&lt;/a> for update Dec 2013&lt;/h3>
&lt;h2 id="snapshot-on-vitamin-d-oct-2011">Snapshot on Vitamin D Oct 2011&lt;/h2>
&lt;p>{IMG(attId=&amp;ldquo;809&amp;rdquo; max =&amp;ldquo;600&amp;rdquo;)}{IMG}&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">The darker the blue the more severe: minimal, mild, moderate, severe, extreme &lt;/span>&lt;/strong>&lt;/p>
&lt;p>Gray = not rated&lt;/p>
&lt;p>{IMG(attId=&amp;ldquo;810&amp;rdquo; max =&amp;ldquo;600&amp;rdquo;)}{IMG}&lt;/p>
&lt;h2 id="chart-is-sorted-by-improvement-top--best">Chart is sorted by improvement: top = best&lt;/h2>
&lt;p>&lt;span style="color:#090;">Light Green = Moderate improvement&lt;/span>; &lt;strong>&lt;span style="color:#090;">Dark green = major improvement&lt;/span>&lt;/strong> ; Gray = No effect&lt;/p></description></item><item><title>Learning about MS and vitamin D in offspring from mice</title><link>/posts/learning-about-ms-and-vitamin-d-in-offspring-from-mice.html</link><pubDate>Wed, 28 Sep 2011 00:00:00 +0000</pubDate><guid>/posts/learning-about-ms-and-vitamin-d-in-offspring-from-mice.html</guid><description>&lt;h1 id="seasonal-gestational-and-postnatal-influences-on-multiple-sclerosis-the-beneficial-role-of-a-vitamin-d-supplementation-during-early-life">Seasonal, gestational and postnatal influences on multiple sclerosis: The beneficial role of a vitamin D supplementation during early life.&lt;/h1>
&lt;p>J Neurol Sci. 2011 Sep 17.&lt;/p>
&lt;p>Fernandes de Abreu DA, Landel V, Féron F.&lt;/p>
&lt;p>There is now strong evidence linking vitamin D, the steroid hormone of sunlight, and Multiple Sclerosis (MS).&lt;/p>
&lt;p>Two of the most intriguing findings are the season of birth and childhood sun exposure effects.&lt;/p>
&lt;p>They both suggest that a vitamin D deficiency during these critical imprinting periods is a risk factor for MS.&lt;/p></description></item><item><title>Multiple Sclerosis etc. strongly associated with Epstein-Barr virus (and vitamin D)</title><link>/posts/multiple-sclerosis-etc-strongly-associated-with-epstein-barr-virus-and-vitamin-d.html</link><pubDate>Thu, 25 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-etc-strongly-associated-with-epstein-barr-virus-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-epstein-barr-virus-and-endogenous-retroviruses-in-multiple-sclerosis---facts-and-hypotheses---march-2021">Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses - March 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evidence-for-the-role-of-a-virus-in-ms-httpswwwnationalmssocietyorgwhat-is-mswhat-causes-msviruses-national-ms-org-2021">&lt;a href="https://www.nationalmssociety.org/What-is-MS/What-Causes-MS/Viruses">Evidence for the role of a virus in MS &lt;/a> National MS Org 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epsteinbarr-virus-in-multiple-sclerosis-theory-and-emerging-immunotherapies---march-2020">Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies - March 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-epstein-barr-virus-in-multiple-sclerosis">The role of Epstein-Barr virus in multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#exploring-the-effect-of-vitamin-d3-supplementation-on-the-anti-ebv-antibody-response-in-relapsing-remitting-multiple-sclerosis---2018">Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis - 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-and-mononucleosis">Epstein-Barr Virus and Mononucleosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-diseases-associated-with-epstein-barr-virus">Other diseases associated with Epstein-Barr Virus&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-epstein-barr-virus-and-endogenous-retroviruses-in-multiple-sclerosis---facts-and-hypotheses---march-2021">Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses - March 2021&lt;/h4>
&lt;p>J Integr Neurosci. 2021 Mar 30;20(1):233-238. &lt;a href="https://doi.org/10.31083/j.jin.2021.01.392.">doi: 10.31083/j.jin.2021.01.392.&lt;/a>&lt;/p></description></item><item><title>There is more in UV than vitamin D which suppresses MS in mice</title><link>/posts/there-is-more-in-uv-than-vitamin-d-which-suppresses-ms-in-mice.html</link><pubDate>Mon, 22 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/there-is-more-in-uv-than-vitamin-d-which-suppresses-ms-in-mice.html</guid><description/></item><item><title>UV produces more than vitamin D</title><link>/posts/uv-produces-more-than-vitamin-d.html</link><pubDate>Sun, 21 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/uv-produces-more-than-vitamin-d.html</guid><description>&lt;h4 id="modulation-of-the-immune-system-by-uv-radiation-more-than-just-the-effects-of-vitamin-d">Modulation of the immune system by UV radiation: more than just the effects of vitamin D?&lt;/h4>
&lt;p>Nat Rev Immunol. 2011 Aug 19. &lt;a href="https://doi.org/10.1038/nri3045.">doi: 10.1038/nri3045.&lt;/a>&lt;/p>
&lt;p>Hart PH, Gorman S, Finlay-Jones JJ.&lt;/p>
&lt;p>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, PO Box 855, Perth, Western Australia 6872, Australia.&lt;/p>
&lt;p>Humans obtain most of their vitamin D through the exposure of skin to sunlight. The immunoregulatory properties of vitamin D have been demonstrated in studies showing that vitamin D deficiency is associated with poor immune function and increased disease susceptibility.&lt;/p></description></item><item><title>MS associated with 29 new and 23 previously known gene variants</title><link>/posts/ms-associated-with-29-new-and-23-previously-known-gene-variants.html</link><pubDate>Wed, 10 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/ms-associated-with-29-new-and-23-previously-known-gene-variants.html</guid><description>&lt;p>&lt;strong>Following press release is translated from German, and is followed by abstract&lt;/strong>&lt;/p>
&lt;h3 id="multiple-sclerosis-is-a-disease-of-the-immune-system">Multiple sclerosis is a disease of the immune system&lt;/h3>
&lt;p>&lt;a href="http://translate.google.com/translate?js=n&amp;amp;prev=_t&amp;amp;hl=en&amp;amp;ie=UTF-8&amp;amp;layout=2&amp;amp;eotf=1&amp;amp;sl=de&amp;amp;tl=en&amp;amp;u=http%3A%2F%2Fidw-online.de%2Fen%2Fnews436197%20">Press Release&lt;/a> Master of Business Administration (FH) Caroline Bahnemann&lt;/p>
&lt;p>Office of Communications and Press&lt;/p>
&lt;p>University of Medicine of the Johannes Gutenberg University Mainz; 08/10/2011 19:00&lt;/p>
&lt;p>International consortium of researchers found 29 new MS gene variants - involved researchers from Mainz&lt;/p>
&lt;p>Scientists have identified &lt;strong>29 new genetic variants associated with disease multiple sclerosis&lt;/strong> . Many of the genes that were identified in the study belong to the immune system - so this is crucial in the development of the disease. Today the work of the international research consortium led by the Universities of Cambridge and Oxford in the &lt;strong>journal Nature&lt;/strong> , was published. It is the largest ever genetic study of multiple sclerosis.&lt;/p></description></item><item><title>Decreased winter sun speeded up subsequent MS development 2X – VA</title><link>/posts/decreased-winter-sun-speeded-up-subsequent-ms-development-2x-va.html</link><pubDate>Tue, 09 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/decreased-winter-sun-speeded-up-subsequent-ms-development-2x-va.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="sun-exposure-vitamin-d-intake-and-progression-to-disability-among-veterans-with-progressive-multiple-sclerosis">Sun Exposure, Vitamin D Intake and Progression to Disability among Veterans with Progressive Multiple Sclerosis.&lt;/h1>
&lt;p>Neuroepidemiology. 2011 Aug 5;37(1):52-57.&lt;/p>
&lt;p>McDowell TY, Amr S, Culpepper WJ, Langenberg P, Royal W, Bever C, Bradham DD.&lt;/p>
&lt;p>MS Center of Excellence-East, Baltimore VAMC, Baltimore, Md., USA.&lt;/p>
&lt;p>Background: Early life events have been suggested to influence multiple sclerosis (MS) susceptibility, and to potentially modulate its clinical course. We assessed vitamin D-related exposures from childhood to disease onset and their associations with MS progression.&lt;/p></description></item><item><title>High vitamin D in moms decreased MS incidence in daughters by 40%</title><link>/posts/high-vitamin-d-in-moms-decreased-ms-incidence-in-daughters-by-40-percent.html</link><pubDate>Tue, 26 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/high-vitamin-d-in-moms-decreased-ms-incidence-in-daughters-by-40-percent.html</guid><description>&lt;h4 id="gestational-vitamin-d-and-the-risk-of-multiple-sclerosis-in-offspring">Gestational vitamin D and the risk of multiple sclerosis in offspring.&lt;/h4>
&lt;p>Ann Neurol. 2011 Jul;70(1):30-40. &lt;a href="https://doi.org/10.1002/ana.22456.">doi: 10.1002/ana.22456.&lt;/a>&lt;/p>
&lt;p>Mirzaei F, Michels KB, Munger K, O&amp;rsquo;Reilly E, Chitnis T, Forman MR, Giovannucci E, Rosner B, Ascherio A.&lt;/p>
&lt;p>Department of Nutrition, Harvard School of Public Health, Boston, MA; Department of Epidemiology, Harvard School of Public Health, Boston, MA. &lt;a href="mailto:fmirzaei@hsph.harvard.edu">fmirzaei@hsph.harvard.edu&lt;/a>.&lt;/p>
&lt;p>OBJECTIVE:Vitamin D may have a protective role in the etiology of multiple sclerosis (MS), but the effect of gestational vitamin D on adult onset MS has not been studied.&lt;/p></description></item><item><title>MS new cases increased 2.5X in 2 years in Isfahan Iran</title><link>/posts/ms-new-cases-increased-25x-in-2-years-in-isfahan-iran.html</link><pubDate>Mon, 18 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/ms-new-cases-increased-25x-in-2-years-in-isfahan-iran.html</guid><description>&lt;h3 id="sharp-increase-in-the-incidence-and-prevalence-of-multiple-sclerosis-in-isfahan-iran">Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran&lt;/h3>
&lt;p>Masoud Etemadifar1,3&lt;/p>
&lt;p>Amir-Hadi Maghzi1,2? &lt;a href="mailto:Maghzi@edc.mui.ac.ir">Maghzi@edc.mui.ac.ir&lt;/a>&lt;/p>
&lt;p>1 Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.&lt;/p>
&lt;p>2 Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK.&lt;/p>
&lt;p>3 Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.&lt;/p>
&lt;p>Amir-Hadi Maghzi, Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Multiple Sclerosis Clinic, Al-Zahra Hospital, Isfahan University of Medical Sciences, Soffeh Street, Isfahan 81744, Iran&lt;/p></description></item><item><title>3X less Multiple Sclerosis with enough vitamin D - Veterans Administration</title><link>/posts/3x-less-multiple-sclerosis-with-enough-vitamin-d-veterans-administration.html</link><pubDate>Thu, 14 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/3x-less-multiple-sclerosis-with-enough-vitamin-d-veterans-administration.html</guid><description>&lt;h4 id="it-appears-that-after-a-hrefpostsmuch-study-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-1242much-studya-that-the-us-veterans-admin-has-decided-that-vitamin-d-does-indeed-help-ms">It appears that after &lt;a href="/posts/much-study" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 1242">much study&lt;/a> that the US Veterans Admin. has decided that Vitamin D does indeed help MS&lt;/h4>
&lt;h5 id="the-va-multiple-sclerosis-center-of-excellencehttpwwwvagovmsvideo_multiple_sclerosis_and_vitamin_dasp-has-a-video-on-the-web-july-2011">The VA &lt;a href="http://www.va.gov/MS/video_multiple_sclerosis_and_vitamin_D.asp">Multiple Sclerosis Center of Excellence&lt;/a> has a video on the web July 2011&lt;/h5>
&lt;h4 id="the-25-minute-video-is-just-people-talking-but-has-the-following-graph">The 2.5 minute video is just people talking, but has the following graph&lt;/h4>
&lt;p>from an unknown study - perhaps in 2011&lt;/p>
&lt;p>{IMG(attId=&amp;ldquo;638&amp;rdquo;)}{IMG}&lt;/p>
&lt;p>The horizontal axis shows the amount of vitamin D in the blood BEFORE getting MS&lt;/p></description></item><item><title>Yet again - more than 10000 IU of vitamin D treats MS</title><link>/posts/yet-again-more-than-10000-iu-of-vitamin-d-treats-ms.html</link><pubDate>Tue, 12 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/yet-again-more-than-10000-iu-of-vitamin-d-treats-ms.html</guid><description>&lt;h3 id="sunshine-vitamin-sheds-light-on-ms">Sunshine Vitamin Sheds Light on MS&lt;/h3>
&lt;p>&lt;a href="http://sciencemedicine.org/content/3/90/90ec102.short%20">Science Translational Medicine Home &amp;gt; 6 July 2011&lt;/a>&lt;/p>
&lt;p>Vol. 3, Issue 90, p. 90ec102&lt;/p>
&lt;p>Rebecca S. Boxer&lt;/p>
&lt;p>Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. E-mail: &lt;a href="mailto:Rebecca.Boxer@UHhospitals.org">Rebecca.Boxer@UHhospitals.org&lt;/a>&lt;/p>
&lt;p>Mother’s advice to get out into the sunshine may be better advice then many realize. Vitamin D, the sunshine vitamin, which is produced in skin exposed to ultraviolet (UVB) light, may have important down-regulatory effects on the inflammatory response in patients.&lt;/p></description></item><item><title>MS reduces vitamin D which then causes osteoporosis</title><link>/posts/ms-reduces-vitamin-d-which-then-causes-osteoporosis.html</link><pubDate>Fri, 08 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/ms-reduces-vitamin-d-which-then-causes-osteoporosis.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="multiple-sclerosis-a-cause-of-secondary-osteoporosis-what-is-the-evidence-and-what-are-the-clinical-implications">Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?&lt;/h1>
&lt;p>Acta Neurol Scand Suppl. 2011;(191):44-9. &lt;a href="https://doi.org/10.1111/j.1600-0404.2011.01543.x.">doi: 10.1111/j.1600-0404.2011.01543.x.&lt;/a>&lt;/p>
&lt;p>Kampman MT, Eriksen EF, Holmøy T.&lt;/p>
&lt;p>Centre for Clinical Research and Education, University Hospital of North Norway, Tromsø, Norway Department of Clinical Medicine, University of Tromsø, Tromsø, Norway Department of Clinical Endocrinology, Oslo University Hospital, Aker, Oslo, Norway Department of Neurology, Akershus University Hospital, Nordbyhagen, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway.&lt;/p></description></item><item><title>Vitamin D patent for treating immune system diseases</title><link>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</link><pubDate>Sun, 03 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</guid><description>&lt;h2 id="wo2008039409httpwwwwipointpatentscopesearchenwo2008039409-world-wide-patent---2008">&lt;a href="http://www.wipo.int/patentscope/search/en/WO2008039409">(WO2008039409)&lt;/a> World-Wide patent - 2008&lt;/h2>
&lt;h4 id="treatment-and-prevention-of-diseases-or-conditions-of-the--immune-system-or-infectious-diseases">TREATMENT AND PREVENTION OF DISEASES OR CONDITIONS OF THE &lt;strong>IMMUNE SYSTEM OR INFECTIOUS DISEASES&lt;/strong>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>allergic rhinitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>eczema,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>psoriasis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>food allergy,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>type-1 diabetes,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>ulcerative colitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Crohn&amp;rsquo;s disease,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>rheumatoid arthritis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>multiple sclerosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>lupus,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>tuberculosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>parasitic infection, etc,&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Vitamin D targets 4 MS genes</title><link>/posts/vitamin-d-targets-4-ms-genes.html</link><pubDate>Thu, 02 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-targets-4-ms-genes.html</guid><description>&lt;h3 id="genetics-and-the-environment-converge-to-dysregulate-n-glycosylation-in-multiple-sclerosis">Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis&lt;/h3>
&lt;p>Nature Communications, Article number: 334, doi:10.1038/ncomms1333&lt;/p>
&lt;p>Haik Mkhikian, Ani Grigorian, Carey F. Li, Hung-Lin Chen, Barbara Newton, Raymond W. Zhou, Christine Beeton, Sevan Torossian, Gevork Grikor Tatarian, Sung-Uk Lee, Ken Lau, Erin Walker, Katherine A. Siminovitch, K. George Chandy, Zhaoxia Yu, James W. Dennis. &lt;strong>Michael Demetriou&lt;/strong> &lt;a href="mailto:mdemetri@uci.edu">mdemetri@uci.edu&lt;/a>&lt;/p>
&lt;p>Received – 02 February 2011, Accepted – 04 May 2011, Published – 31 May 2011&lt;/p></description></item><item><title>300000 IU vitamin D monthly may treat MS</title><link>/posts/300000-iu-vitamin-d-monthly-may-treat-ms.html</link><pubDate>Sun, 08 May 2011 00:00:00 +0000</pubDate><guid>/posts/300000-iu-vitamin-d-monthly-may-treat-ms.html</guid><description>&lt;h2 id="therapeutic-effect-of-vitamin-d3-in-multiple-sclerosis-patients">Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients.&lt;/h2>
&lt;p>Immunol Invest. 2011 May 4.&lt;/p>
&lt;p>Mosayebi G, Ghazavi A, Ghasami K, Jand Y, Kokhaei P.&lt;/p>
&lt;p>Molecular and Medicine Research Center, Department of Immunology, School of Medicine, Arak University of Medical Sciences, Arak, I.R. Iran.&lt;/p>
&lt;p>Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the central nervous system are damaged. The damage leads to demyelination and scarring as well as a broad spectrum of signs and symptoms. The epidemiological data suggest a possible influence of vitamin D as an immunomodulatory agent on multiple sclerosis susceptibility as well as on clinical course of the disease. We investigated the effects of short-term vitamin D3 therapy on Iranian patients with MS.&lt;/p></description></item><item><title>Reduced vitamin D and BMD and Neurological Conditions</title><link>/posts/reduced-vitamin-d-and-bmd-and-neurological-conditions.html</link><pubDate>Wed, 04 May 2011 00:00:00 +0000</pubDate><guid>/posts/reduced-vitamin-d-and-bmd-and-neurological-conditions.html</guid><description>&lt;h1 id="bone-mineral-density-in-adults-disabled-through-acquired-neurological-conditions-a-review">Bone Mineral Density in Adults Disabled Through Acquired Neurological Conditions: A Review&lt;/h1>
&lt;p>Journal of Clinical Densitometry&lt;/p>
&lt;p>Volume 14, Issue 2 , Pages 85-94, April 2011&lt;/p>
&lt;p>Bone Mineral Density in Adults Disabled Through Acquired Neurological Conditions: A Review&lt;/p>
&lt;p>Áine Carroll&lt;/p>
&lt;p>Received 10 June 2010; received in revised form 12 December 2010; accepted 13 December 2010. published online 07 April 2011.&lt;/p>
&lt;p>This article is a review of the changes in bone mineral density (BMD), which occur in a number of acquired neurological conditions resulting in disability.&lt;/p></description></item><item><title>MS is related to latitude – conclusion from 321 studies</title><link>/posts/ms-is-related-to-latitude-conclusion-from-321-studies.html</link><pubDate>Sun, 01 May 2011 00:00:00 +0000</pubDate><guid>/posts/ms-is-related-to-latitude-conclusion-from-321-studies.html</guid><description>&lt;h3 id="ms-is-significantly-associated-with-the-prevalence-of-multiple-sclerosis-a-meta-analysis">MS is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry. 2011 Apr 8. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B.&lt;/p>
&lt;p>Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.&lt;/p>
&lt;p>Background There is a striking latitudinal gradient in multiple sclerosis (MS) prevalence, but exceptions in Mediterranean Europe and northern Scandinavia, and some systematic reviews, have suggested that the gradient may be an artefact. The authors sought to evaluate the association between MS prevalence and latitude by meta-regression.&lt;/p></description></item><item><title>Vitamin D is a T-cell modulator in multiple sclerosis – April 2011.</title><link>/posts/vitamin-d-is-a-t-cell-modulator-in-multiple-sclerosis-april-2011.html</link><pubDate>Sun, 03 Apr 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-a-t-cell-modulator-in-multiple-sclerosis-april-2011.html</guid><description>&lt;h1 id="vitamin-d-as-a-t-cell-modulator-in-multiple-sclerosis">Vitamin D as a T-cell modulator in multiple sclerosis&lt;/h1>
&lt;p>Vitam Horm. 2011;86:401-28.&lt;/p>
&lt;p>Smolders J, Damoiseaux J.&lt;/p>
&lt;p>School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Internal Medicine, Division of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.&lt;/p>
&lt;p>Vitamin D is a potent immune modulator, keeping the T-cell compartment in a more tolerogenic state. Multiple sclerosis (MS), a disease in which an autoreactive T-cell response contributes to inflammation in the central nervous system, has been associated with vitamin D deficiency. The effects of vitamin D on the immune system are believed to be an important driver of this association. In this chapter, we elaborate on vitamin D as a modulator of the T-cell response. This discussion will be placed in the perspective of MS as a T-cell-mediated disease and in the perspective of the numerous association studies on vitamin D deficiency and multiple health outcomes.&lt;/p></description></item><item><title>2800 IU vitamin D daily did not decrease bone loss for those with MS</title><link>/posts/2800-iu-vitamin-d-daily-did-not-decrease-bone-loss-for-those-with-ms.html</link><pubDate>Wed, 30 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/2800-iu-vitamin-d-daily-did-not-decrease-bone-loss-for-those-with-ms.html</guid><description>&lt;h1 id="can-vitamin-d3-supplementation-prevent-bone-loss-in-persons-with-ms-a-placebo-controlled-trial">Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial.&lt;/h1>
&lt;p>J Neurol. 2011 Mar 13.&lt;/p>
&lt;p>Steffensen LH, Jørgensen L, Straume B, Mellgren SI, Kampman MT.&lt;/p>
&lt;p>Department of Neurology, University Hospital of North Norway, Tromsø, Norway, &lt;a href="mailto:linn.hofsoy.steffensen@unn.no">linn.hofsoy.steffensen@unn.no&lt;/a>.&lt;/p>
&lt;p>Multiple sclerosis (MS) is a possible cause of secondary osteoporosis. In this phase II trial we assessed whether a weekly dose of 20,000 IU vitamin D(3) prevents bone loss in ambulatory persons with MS age 18-50 years. ClinicalTrials.gov ID NCT00785473. All patients managed at the University Hospital of North Norway who fulfilled the main inclusion criteria were invited to participate in this double-blinded trial. Participants were randomised to receive &lt;strong>20,000 IU vitamin D(3) or placebo once a week&lt;/strong> and 500 mg calcium daily for 96 weeks. The primary outcome was the effect of the intervention on percentage change in bone mineral density (BMD) at the hip, the spine, and the ultradistal radius over the study period. Of 71 participants randomised, 68 completed. Mean serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> levels in the intervention group increased from 55 nmol/L at baseline to 123 nmol/L at week 96. After 96 weeks, percentage change in BMD did not differ between groups at any site. BMD decreased at the hip, by 1.4% in the placebo group (95% CI -2.3 to -0.4, SD 2.7, p = 0.006) and by 0.7% in the treatment group (-1.6 to 0.2, 2.7, p = 0.118), difference 0.7% (-1.9 to 0.7, p = 0.332). Findings were not altered by adjustment for sex or serum 25(OH)D.&lt;/p></description></item><item><title>Lack of sun and lack of vitamin D are both MS risk factors</title><link>/posts/lack-of-sun-and-lack-of-vitamin-d-are-both-ms-risk-factors.html</link><pubDate>Wed, 30 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/lack-of-sun-and-lack-of-vitamin-d-are-both-ms-risk-factors.html</guid><description>&lt;h1 id="sun-exposure-and-vitamin-d-are-independent-risk-factors-for-cns-demyelination">Sun exposure and vitamin D are independent risk factors for CNS demyelination.&lt;/h1>
&lt;p>Neurology. 2011 Feb 8;76(6):540-8.&lt;/p>
&lt;p>Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, Kilpatrick TJ, Dwyer T, Coulthard A, Chapman C, van der Mei I, Williams D, McMichael AJ.&lt;/p>
&lt;p>National Centre for Epidemiology and Population Health, The Australian National University, Canberra 0200, Australia. &lt;a href="mailto:Robyn.Lucas@anu.edu.au">Robyn.Lucas@anu.edu.au&lt;/a>&lt;/p>
&lt;p>OBJECTIVES: To examine whether past and recent sun exposure and vitamin D status (serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> levels) are associated with risk of first demyelinating events (FDEs) and to evaluate the contribution of these factors to the latitudinal gradient in FDE incidence in Australia.&lt;/p></description></item><item><title>Unable to find a gene linking vitamin D and MS</title><link>/posts/unable-to-find-a-gene-linking-vitamin-d-and-ms.html</link><pubDate>Tue, 29 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/unable-to-find-a-gene-linking-vitamin-d-and-ms.html</guid><description>&lt;h1 id="vitamin-d-metabolic-pathway-genes-and-risk-of-multiple-sclerosis-in-canadians">Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.&lt;/h1>
&lt;p>Neurol Sci. 2011 Mar 25.&lt;/p>
&lt;p>Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC.&lt;/p>
&lt;p>Wellcome Trust Centre for Human Genetics and Department of Clinical Neurology, University of Oxford, Oxford, UK.&lt;/p>
&lt;p>BACKGROUND: Multiple sclerosis (MS) is determined by interactions between genes and environment and the influence of vitamin D adequacy has been proposed. Previous studies have shown that serum 25-hydroxyvitaminD (25(OH)D) levels are genetically influenced. Polymorphisms in vitamin D pathway genes are candidates for association with MS susceptibility.&lt;/p></description></item><item><title>Increased sun and vitamin D both reduced MS risk</title><link>/posts/increased-sun-and-vitamin-d-both-reduced-ms-risk.html</link><pubDate>Sun, 13 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/increased-sun-and-vitamin-d-both-reduced-ms-risk.html</guid><description>&lt;h3 id="sun-exposure-and-vitamin-d-are-independent-risk-factors-for-cns-demyelination">Sun exposure and vitamin D are independent risk factors for CNS demyelination&lt;/h3>
&lt;ol>
&lt;li>
&lt;p>R.M. Lucas, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A.-L. Ponsonby, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>K. Dear, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>P.C. Valery, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>M.P. Pender, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>B.V. Taylor, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>T.J. Kilpatrick, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>T. Dwyer, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A. Coulthard, FRANZCR,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>C. Chapman, FRACP,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>I. van der Mei, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>D. Williams, PhD and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A.J. McMichael, PhD&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>From the National Centre for Epidemiology and Population Health (R.M.L., K.D., A.J.M.), The Australian National University, Canberra; Murdoch Childrens Research Institute (A.-L.P., T.D.), Melbourne; Queensland Institute of Medical Research (P.C.V.), Brisbane; The University of Queensland and Royal Brisbane and Women&amp;rsquo;s Hospital (M.P.P., A.C.), Brisbane; Menzies Research Institute (B.V.T., I.v.d.M.), Hobart; Centre for Neuroscience (T.J.K.), The University of Melbourne, Melbourne; Department of Neurology (C.C.), Barwon Health, Geelong; and Department of Neurophysiology (D.W.), John Hunter Hospital, Newcastle, Australia.&lt;/p></description></item><item><title>Vitamin D and MS - Correlation - Causality – Controversy</title><link>/posts/vitamin-d-and-ms-correlation-causality-controversy.html</link><pubDate>Sun, 13 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-ms-correlation-causality-controversy.html</guid><description>&lt;h1 id="vitamin-d-and-multiple-sclerosis-correlation-causality-and-controversy">Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy&lt;/h1>
&lt;p>Autoimmune Dis. 2011; 2011: 629538.&lt;/p>
&lt;p>Published online 2010 October 5. &lt;a href="https://doi.org/10.4061/2011/629538.">doi: 10.4061/2011/629538.&lt;/a>&lt;/p>
&lt;p>Copyright © 2011 Joost Smolders.&lt;/p>
&lt;p>Joost &lt;a href="mailto:Smoldersj.smolders@mumc.nl">Smoldersj.smolders@mumc.nl&lt;/a>, 2*&lt;/p>
&lt;p>1Division of Clinical and Experimental Immunology, Department of Internal Medicine and School for Mental Health and Neuroscience, Maastricht University Medical Center, Universiteitssingel 50, P.O. Box 616, 6200 MD Maastricht, The Netherlands&lt;/p>
&lt;p>2Academic MS Center Limburg, Orbis Medical Center, P.O. Box 5500, 6130 MB Sittard, The Netherlands&lt;/p></description></item><item><title>More females have MS – perhaps due to vitamin D deficiency</title><link>/posts/more-females-have-ms-perhaps-due-to-vitamin-d-deficiency.html</link><pubDate>Tue, 01 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/more-females-have-ms-perhaps-due-to-vitamin-d-deficiency.html</guid><description>&lt;h1 id="the-increasing-incidence-and-prevalence-of-female-multiple-sclerosis---a-critical-analysis-of-potential-environmental-factors">The increasing incidence and prevalence of female multiple sclerosis - a critical analysis of potential environmental factors.&lt;/h1>
&lt;p>Autoimmun Rev. 2011 Feb 24.&lt;/p>
&lt;p>Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O.&lt;/p>
&lt;p>Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany; Department of Neurology, Christian-Doppler Klinik, Paracelsus Medizinische Universität, Salzburg, Austria.&lt;/p>
&lt;p>Multiple sclerosis (MS) is the most common acquired inflammatory demyelinating disorder of the central nervous system (CNS). Not unlike many inflammatory diseases with a presumed autoimmune pathogenesis, it has been established that there is a female preponderance in prevalence. While in the past it was shown that there are &lt;strong>two women for every man with a diagnosis of MS&lt;/strong> , recent serial cross-sectional assessments provide compelling evidence for an increase of the female to male sex ratio in patients with relapsing-remitting MS over the last decades. An understanding of this phenomenon might provide key insights into the pathogenesis of the disease but also may have implications for health-care strategies and further research efforts.&lt;/p></description></item><item><title>20000 IU vitamin D and MS – less fatigue and relapse</title><link>/posts/20000-iu-vitamin-d-and-ms-less-fatigue-and-relapse.html</link><pubDate>Fri, 17 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/20000-iu-vitamin-d-and-ms-less-fatigue-and-relapse.html</guid><description>&lt;h1 id="safety-and-t-cell-modulating-effects-of-high-dose-vitamin-d3-supplementation-in-multiple-sclerosis">Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis&lt;/h1>
&lt;p>PLoS ONE 5(12): e15235. doi:10.1371/journal.pone.0015235, Clinicaltrials.gov NCT00940719&lt;/p>
&lt;p>Joost Smolders1,2,3*, Evelyn Peelen1,2,3, Mariëlle Thewissen2, Jan Willem Cohen Tervaert1,2,5, Paul Menheere4, Raymond Hupperts1,3, Jan Damoiseaux2,5&lt;/p>
&lt;p>1 School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands,&lt;/p>
&lt;p>2 Division of Clinical and Experimental Immunology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands,&lt;/p></description></item><item><title>Lack of sunshine associated with MS two years sooner – 2 VHA articles 2010</title><link>/posts/lack-of-sunshine-associated-with-ms-two-years-sooner-2-vha-articles-2010.html</link><pubDate>Thu, 16 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/lack-of-sunshine-associated-with-ms-two-years-sooner-2-vha-articles-2010.html</guid><description>&lt;p> &lt;/p>
&lt;h2 id="and--cod-liver-oil-associated-with-ms-4-years-later">And – Cod Liver oil associated with MS 4 years later&lt;/h2>
&lt;h1 id="sun-exposure-vitamin-d-and-age-at-disease-onset-in-relapsing-multiple-sclerosis">Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis&lt;/h1>
&lt;p>Vol. 36, No. 1, 2011&lt;/p>
&lt;p>Tzu-Yun McDowella, b, Sania Amrb, William J. Culpeppera, d, Patricia Langenbergb, Walter Royala, c, Christopher Bevera, c, Douglas D. Bradhama, e&lt;/p>
&lt;p>aMS Center of Excellence-East, Baltimore VAMC &lt;a href="mailto:tycmcdowell@hotmail.com">tycmcdowell@hotmail.com&lt;/a>&lt;/p>
&lt;p>Departments of&lt;/p>
&lt;p>bEpidemiology and Public Health and&lt;/p>
&lt;p>cNeurology, School of Medicine, and&lt;/p>
&lt;p>dDepartment of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Md., and&lt;/p></description></item><item><title>Lack of UV 20X more associated with MS than any other variable</title><link>/posts/lack-of-uv-20x-more-associated-with-ms-than-any-other-variable.html</link><pubDate>Thu, 16 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/lack-of-uv-20x-more-associated-with-ms-than-any-other-variable.html</guid><description>&lt;h4 id="a-quantitative-analysis-of-suspected-environmental-causes-of-ms">A Quantitative Analysis of Suspected Environmental Causes of MS.&lt;/h4>
&lt;p>Can J Neurol Sci 38(1):98-105 (2011)&lt;/p>
&lt;p>Scott Sloka, Claudia Silva, William Pryse-Phillips, Scott Patten, Luanne Metz and V Wee Yong&lt;/p>
&lt;p>Department of Neurology, Grand River Hospital, Kitchener, Ontario, Canada.&lt;/p>
&lt;p>Background: Multiple sclerosis (MS) is a disease with purported environmental causes. Consistent correlations have been found in various settings for &lt;strong>latitude, smoking exposure, sunlight, and vitamin D deficiency&lt;/strong> . We analysed the contribution of various environmental factors to the risk of developing MS from a population perspective.&lt;/p></description></item><item><title>MS Trust in UK is concerned about lack of vitamin D product</title><link>/posts/ms-trust-in-uk-is-concerned-about-lack-of-vitamin-d-product.html</link><pubDate>Thu, 18 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/ms-trust-in-uk-is-concerned-about-lack-of-vitamin-d-product.html</guid><description>&lt;h1 id="vitamin-d-deficiency-and-insufficiency---available-products">Vitamin D deficiency and insufficiency - available products&lt;/h1>
&lt;p>from &lt;a href="http://www.mstrust.org.uk/news/article.jsp?id=4331">http://www.mstrust.org.uk/news/article.jsp?id=4331&lt;/a>&lt;/p>
&lt;p>16 November 2010&lt;/p>
&lt;p>There are currently a number of supply issues surrounding vitamin D preparations, with the limited number of licensed preparations available being confined to high strength injections for treatment of adult deficiency and oral vitamin drops for paediatric insufficiency.&lt;/p>
&lt;p>A recent BMJ article highlighted the problem of vitamin D insufficiency in the UK population. The article cites a survey in which more than 50% of the adult population had insufficiency and 16% had severe insufficiency, and goes on to discuss a large body of observational evidence associating such insufficiency with an increased risk of mortality. The authors report that expert consensus suggests vitamin D status measured by 25-hydroxyvitamin D (25-OHD) should be 75 nmol/L (30 ?g/L) or more, with deficiency represented by 25-OHD&amp;lt;25 nmol/L and insufficiency represented by 25-OHD of 25-50 nmol/L. We are aware that organisations have or are developing their own local guidance on vitamin D deficiency and insufficiency.&lt;/p></description></item></channel></rss>